Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN360116 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Interleukin-1 Receptor-Associated Kinase 1 (IRAK1) (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- C-Term
- Vial size
- 0.4 mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at-20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex.
Characterization of Pellino2, a substrate of IRAK1 and IRAK4.
Pellino3, a novel member of the Pellino protein family, promotes activation of c-Jun and Elk-1 and may act as a scaffolding protein.
IRAK: a kinase associated with the interleukin-1 receptor.
Jiang Z, Johnson HJ, Nie H, Qin J, Bird TA, Li X
The Journal of biological chemistry 2003 Mar 28;278(13):10952-6
The Journal of biological chemistry 2003 Mar 28;278(13):10952-6
Characterization of Pellino2, a substrate of IRAK1 and IRAK4.
Strelow A, Kollewe C, Wesche H
FEBS letters 2003 Jul 17;547(1-3):157-61
FEBS letters 2003 Jul 17;547(1-3):157-61
Pellino3, a novel member of the Pellino protein family, promotes activation of c-Jun and Elk-1 and may act as a scaffolding protein.
Jensen LE, Whitehead AS
Journal of immunology (Baltimore, Md. : 1950) 2003 Aug 1;171(3):1500-6
Journal of immunology (Baltimore, Md. : 1950) 2003 Aug 1;171(3):1500-6
IRAK: a kinase associated with the interleukin-1 receptor.
Cao Z, Henzel WJ, Gao X
Science (New York, N.Y.) 1996 Feb 23;271(5252):1128-31
Science (New York, N.Y.) 1996 Feb 23;271(5252):1128-31
No comments: Submit comment
No validations: Submit validation data